Creative Medical Technology Holdings, Inc. (CELZ) Research
Creative Medical Technology Holdings, Inc., a biotechnology firm based in Phoenix, Arizona, specializes in advancing adult stem cell treatments. The company's core focus spans several medical fields, including immunology, urology, orthopedics, and neurology. Among its therapeutic offerings are CaverStem, designed to address erectile dysfunction; FemCelz, which aims to restore genital sensitivity and alleviate dryness; StemSpine, developed to treat chronic lower back pain; ImmCelz, intended for stroke patients; and OvaStem, a solution for female infertility.
Market snapshot
- Symbol
- CELZ
- Price
- $2.23
- Day change
- -0.45%
- Market cap
- $5.8M
- P/E ratio
- -1.43x
- 52-week range
- 1.504-6.25
- Sector
- Healthcare
- Industry
- Biotechnology
- Next earnings
- in 2 months
Recent news
- Creative Medical Technology opens nationwide burn-pit data registry
Creative Medical Technology Holdings Inc (NASDAQ:CELZ) has moved Project PHOENIX into a nationwide virtual data-collection phase, opening enrollment for a regulatory-approved registry that the company designed to support U.S. veterans exposed to burn pits and other toxic environmental hazards.
- Creative Medical Technology opens nationwide burn-pit data registry
Creative Medical Technology Holdings Inc (NASDAQ:CELZ) has moved Project PHOENIX into a nationwide virtual data-collection phase, opening enrollment for a...
Peer companies
Recent insider activity
- Finger Michael H. — S-Sale (750 shares) on 2025-02-18
- Finger Michael H. — S-Sale (750 shares) on 2025-02-19
- Warbington Timothy — P-Purchase (200 shares) on 2023-06-28
- Warbington Timothy — P-Purchase (200 shares) on 2023-06-27
- Warbington Timothy — P-Purchase (300 shares) on 2023-06-27
Open Creative Medical Technology Holdings, Inc. (CELZ) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.